COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI
NCT ID: NCT05790902
Last Updated: 2023-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
142 participants
INTERVENTIONAL
2022-09-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi
NCT05977647
Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones
NCT06999135
Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric Stones
NCT05789732
Comparative Study for Medical Therapy for Lower Ureteral Stones
NCT06707181
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
NCT01560091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Silodosin Group
The patients used Silodosin for ureteric calculi
Silodosin
The patients used Silodosin for Medical expulsive therapy of ureteric calculi
Tamsulosin Group
The patients used Tamsulosin for ureteric calculi
Tamsulosin
The patients used Tamsulosin for Medical expulsive therapy of ureteric calculi
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Silodosin
The patients used Silodosin for Medical expulsive therapy of ureteric calculi
Tamsulosin
The patients used Tamsulosin for Medical expulsive therapy of ureteric calculi
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Armed Forces Institute of Urology, Rawalpindi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AJ Arif
DR ABDUL JABBAR ARIF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AFIU Rawalpindi
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AFIU-2022-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.